Početna › Rak rektuma › Missouri
Kliničke studije za Rak rektuma u državi Missouri
14 studija za Rak rektuma traži sudionike na lokacijama u državi Missouri.
Gradovi u državi Missouri
- St. Louis11 studija
- Kansas City5 studija
- Saint Joseph4 studija
- O'Fallon3 studija
- Springfield3 studija
- Cape Girardeau3 studija
- Rolla3 studija
- Joplin3 studija
Službeni tekst studije (engleski)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- i još 23
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07283939Family Communications After Genetic Testing
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- i još 18
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Saint Luke's Cancer Institute ( Site 0082), Kansas City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06997497Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Washington University School of Medicine, St Louis
U tijeku regrutacijaOpažajna studija
Od 18 do 50 godina · Žene · Ažurirano 2. ruj 2026. · NCT06904365Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- i još 14
U tijeku regrutacija
Od 45 do 70 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT05080673Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Mercy Hospital Saint Louis, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. srp 2026. · NCT06205485Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Washington University School of Medicine, St Louis
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 14. srp 2026. · NCT06340646Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- i još 3
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Washington University, St Louis
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT06051695A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Missouri Cancer Associates, Columbia
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT07011576Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
- Washington University School of Medicine, St Louis
U tijeku regrutacija
Od 19 godina i više · Oba spola · Ažurirano 12. velj 2026. · NCT04339374Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. velj 2026. · NCT03516708SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Washington University, St Louis
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2025. · NCT06682793Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.